NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,606,647 | +1.5% | 35,407 | +0.5% | 0.94% | +4.7% |
| Q2 2023 | $3,553,534 | +11.3% | 35,214 | +1.5% | 0.90% | +7.0% |
| Q1 2023 | $3,192,113 | +3.2% | 34,696 | +1.7% | 0.84% | +0.8% |
| Q4 2022 | $3,094,267 | +19.3% | 34,108 | -0.0% | 0.84% | +7.5% |
| Q3 2022 | $2,593,000 | -8.2% | 34,110 | +2.1% | 0.78% | -5.4% |
| Q2 2022 | $2,824,000 | +41.7% | 33,412 | +46.4% | 0.82% | +68.4% |
| Q1 2022 | $1,993,000 | +8.6% | 22,817 | +8.7% | 0.49% | -3.6% |
| Q4 2021 | $1,835,000 | +11.3% | 20,982 | +4.1% | 0.51% | -1.6% |
| Q3 2021 | $1,648,000 | -1.3% | 20,149 | +10.2% | 0.51% | -4.8% |
| Q2 2021 | $1,669,000 | +13.5% | 18,292 | +6.4% | 0.54% | +1.1% |
| Q1 2021 | $1,470,000 | -7.5% | 17,197 | +2.2% | 0.53% | -17.7% |
| Q4 2020 | $1,589,000 | +20.9% | 16,825 | +11.4% | 0.65% | -6.3% |
| Q3 2020 | $1,314,000 | +2.9% | 15,110 | +3.3% | 0.69% | -4.3% |
| Q2 2020 | $1,277,000 | +5.0% | 14,622 | -0.8% | 0.72% | -1.1% |
| Q1 2020 | $1,216,000 | +30300.0% | 14,744 | +32664.4% | 0.73% | +24300.0% |
| Q4 2017 | $4,000 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |